ConvaTec Group PLC Non-Executive Director appointment (9330V)
17 December 2021 - 12:59AM
UK Regulatory
TIDMCTEC
RNS Number : 9330V
ConvaTec Group PLC
16 December 2021
ConvaTec Group PLC
Non-Executive Director Appointment
Reading, United Kingdom - 16(th) December 2021
ConvaTec Group PLC ("ConvaTec" or "the Company") is pleased to
announce the appointment of Kimberly ("Kim") Lody as a
Non-Executive Director of the Company with effect from 1 February
2022. Kim will join ConvaTec's Nomination and Remuneration
committees on the same date.
Since 2019, Kim has been the President and Chief Executive O
ffice r of Sonida Senior Living Corporation, one of the USA's
largest owner-operators of senior housing communities. Kim has an
extensive background in international, multi-cultural environments
with more than 25 years of healthcare experience including
alternate site healthcare services, durable medical equipment and
medical devices.
From 2011-2019, Kim served firstly as President of Resound and
then as SVP and President of GN Hearing, both of which are medical
device divisions of the GN Group. From 2009 - 2011, Kim was Vice
President of Marketing and then President of Chronic Care for the
U.S. subsidiary of Coloplast. From 2004-2009, Kim was an
independent consultant to the healthcare sector. Her earlier career
included serving as COO of Senior Home Care; CMO of Gentiva Health
Services; and VP of Managed Care Programs for Apria Healthcare.
Kim holds a bachelor's degree in Business Administration from
Hiram College in Ohio and an MBA with a concentration in finance
from Wake Forest University, North Carolina.
John McAdam, Chairman of ConvaTec, commented:
"I am delighted to welcome Kim to our Board. She has deep
healthcare knowledge, an impressive track record and brings to the
Board very relevant international, commercial and operational
experience. We look forward to Kim's contribution to our Board
discussions."
This announcement is made in accordance with Listing Rule
9.6.11R (1). No other information is required to be disclosed in
accordance with Listing Rule 9.6.13.
Enquiries:
Analysts and Investors
Kate Postans, Vice President, Investor Relations +44(0)7826 447
807
ir@convatec.com
Media
Buchanan: Chris Lane +44(0)207 466 5000
ConvaTec Group PLC's LEI code is 213800LS272L4FIDOH92
About ConvaTec Group PLC
ConvaTec is a global medical products and technologies company
focused on therapies for the management of chronic conditions, with
leading market positions in advanced wound care, ostomy care,
continence and critical care, and infusion care. Our vision, which
encompasses our purpose, is: Pioneering trusted medical solutions
to improve the lives we touch. Our products provide a range of
clinical and economic benefits including infection prevention,
protection of at-risk skin, improved patient outcomes and reduced
total cost of care. To learn more about ConvaTec, please visit
www.convatecgroup.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOADKABQNBDDFBD
(END) Dow Jones Newswires
December 16, 2021 08:59 ET (13:59 GMT)
Convatec (LSE:CTEC)
Historical Stock Chart
From Feb 2024 to Mar 2024
Convatec (LSE:CTEC)
Historical Stock Chart
From Mar 2023 to Mar 2024